Novartis Reports Real World Evidence from Psoriasis patients indicating Treatment to Exceed Beyond Clear Skin and safety

 Novartis Reports Real World Evidence from Psoriasis patients indicating Treatment to Exceed Beyond Clear Skin and safety

Novartis Reports Real World Evidence from Psoriasis patients indicating Treatment to Exceed Beyond Clear Skin and safety

Shots:

  • The survey enrolled 300 (US respondents) psoriasis patients are interested in additional benefits i.e. no. of years of proven efficacy and safety with no injection site reactions in addition to clear skin
  • Survey also indicated that efficacy of drug in treating multiple manifestations of psoriatic disease was also important for patients while no. of injections per dose and their frequency was less preferred in patients
  • This online DCE survey is aimed to help dermatologists understand patient’s preference for five selected attributes differentiating biologic treatments from moderate-to-severe plaque psoriasis

Click here to read full press release/ article | Ref: Novartis | Image: Wall Street

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post